The FDA has granted Actavis approval for its oxymorphone hydrochloride extended-release tablets in five strengths to treat moderate to severe pain in patients who need continuous around-the-clock opioid treatment. The drug is a generic version of Opana ER, made by Endo Health Solutions.
Generic Opana obtains federal approval
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|